National Institute of Allergy and Infectious Diseases (NIAID) Clinical Data and Safety Management Center (CDSMC) (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-22-058 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to solicit applications for the NIAID CDSMC, which will support a broad range of critical support services, including data management and processing, safety and pharmacovigilance management and processing, and sample tracking systems for NIAID-funded clinical trials, integrated studies of underlying mechanisms, clinical studies (e.g., longitudinal studies, genetic studies, etc.), and studies to identify and validate surrogates/biomarkers of immune-mediated diseases in the areas of asthma and allergic diseases, autoi...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 9, 2022 Category: Research Source Type: funding
Allergy and Asthma Statistical and Clinical Coordinating Center (AA-SCCC) (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-22-054 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to solicit applications for an Allergy and Asthma Statistical and Clinical Coordinating Center (AA-SCCC) to provide a broad range of support critical for design, development, execution, and analysis of clinical research in allergic diseases and asthma. The major clinical research programs to be supported by the AA-SCCC include the Atopic Dermatitis Research Network, Consortium for Food Allergy Research, Childhood Asthma in Urban Settings Clinical Research Network, and Immune Tolerance Network. The AA-SCCC also may s...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 9, 2022 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for Allergy and Asthma Statistical and Clinical Coordinating Center (AA-SCCC) (U01 Clinical Trial Not Allowed)
Notice NOT-AI-22-061 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 21, 2022 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for National Institute of Allergy and Infectious Diseases (NIAID) Clinical Data and Safety Management Center (CDSMC) (U01 Clinical Trial Not Allowed)
Notice NOT-AI-22-063 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 21, 2022 Category: Research Source Type: funding
Limited Competition: Cancer Immune Monitoring and Analysis Centers (CIMACs) and Cancer Immunologic Data Center (CIDC) (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-22-038 from the NIH Guide for Grants and Contracts. Through this limited competition Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications to continue support for the Cancer Immune Monitoring and Analysis Centers Cancer Immunologic Data Center (CIMAC-CIDC) Network. The CIMAC-CIDC is a network of laboratories (CIMACs) and a bioinformatics center (CIDC) established to perform correlative studies using biospecimens from cancer immunotherapy clinical trials. Applying a comprehensive set of state-of-the-art immunoprofiling assays and bioinformatics pipelin...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 15, 2022 Category: Research Source Type: funding
Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-DA-23-052 from the NIH Guide for Grants and Contracts. The National Institute on Drug Abuse (NIDA) supports a program of longitudinal cohorts to address emerging and high priority research on HIV/AIDS in the context of injection and non-injection substance abuse. These cohorts provide a strong resource platform for current and future collaborative efforts with other investigators to address emerging questions related to HIV pathogenesis, prevention, and treatment in the context of substance abuse, as well as to foster the creativity and efficiency of investigatorinitiated research projects. The d...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 13, 2022 Category: Research Source Type: funding
Transgender People: Immunity, Prevention, and Treatment of HIV and STIs (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-22-186 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support hypothesis-generating research in transgender people with the objective of characterizing the biological and immunological impact of the interventions (hormones, drugs and surgical) used for gender reassignment and their impact on susceptibility to HIV and other sexually transmitted infections (STI). (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 19, 2022 Category: Research Source Type: funding
NIH All About Grants Podcast: Building Bridges
Bonnie Burgess-Beusse, Ph.D., Program Director: Division of Digestive Diseases and Nutrition, NIDDK, NIH
Lakshmi Ramachandra, Ph.D., Section Chief; Tuberculosis Research Advancement Centers, NIAID, NIH
You may have heard that NIH can provide limited, interim research support for applications with creative and innovative approaches that fell just outside the payline. These “bridge awards” are helpful for researchers to gather additional data to revise their current application. But, how do we decide on which applications to support this way?
Join us for this NIH All About Grants podcast episode to learn more about R56/b...
Source: NIH Extramural Nexus - May 12, 2022 Category: Research Authors: NIH Staff Tags: New Resources Bridge Awards podcast Source Type: funding
Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-DA-23-040 from the NIH Guide for Grants and Contracts. The National Institute on Drug Abuse (NIDA) supports a program of longitudinal cohorts to address emerging and high priority research on HIV/AIDS in the context of injection and non-injection substance abuse. These cohorts provide a strong resource platform for current and future collaborative efforts with other investigators to address emerging questions related to HIV pathogenesis, prevention, and treatment in the context of substance abuse, as well as to foster the creativity and efficiency of investigatorinitiated research projects. The d...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 26, 2022 Category: Research Source Type: funding
Development and Optimization of Next-Generation Immunological Assays to Support Influenza Clinical Studies and Trials (UH2/UH3 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-22-020 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for collaborative, multidisciplinary research to develop and optimize next-generation immunological assays that will be readily utilized for influenza clinical studies and trials by the end of the UH2/UH3 project period. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 5, 2022 Category: Research Source Type: funding
NIAID Research Education Program (R25 Clinical Trial Not Allowed)
Funding Opportunity PAR-22-134 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this National Institute of Allergy and infectious Diseases (NIAID) R25 program is to support educational activities that complement and/or enhance the training of a diverse workforce to meet the nations biomedical, behavioral and clinical research needs of NIAID mission areas. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 15, 2022 Category: Research Source Type: funding
Immune Drivers of Autoimmune Disease (IDAD) (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-22-012 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to participate in the Immune Drivers of Autoimmune Disease (IDAD) cooperative research program, which will focus on defining the immunologic states and dynamics that drive autoimmune disease. The main objective of this program is to enhance our understanding of the immunologic processes, events, and changes that underlie the clinical manifestations of autoimmune diseases, including disease flare, remission, and progression of established disease, as well as the progression from ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 24, 2022 Category: Research Source Type: funding
Notice of Change to Eligibility Information in RFA-AI-21-079, Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional)
Notice NOT-AI-22-031 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 4, 2022 Category: Research Source Type: funding
Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional)
Funding Opportunity RFA-AI-21-079 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications from single institutions or consortia of institutions to participate in the Asthma and Allergic Diseases Cooperative Research Centers (AADCRC) program. The program will support centers that integrate clinical and translational research to conduct studies on the mechanisms underlying the onset and progression of diseases of interest, including asthma, rhinitis (allergic and non-allergic), chronic rhinosinusitis, atopic dermatitis, food allergy, and drug allerg...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 22, 2021 Category: Research Source Type: funding
Notice of Participation of the National Institute of Allergy and Infectious Diseases (NIAID) in PAR-21-189, Medical Scientist Training Program (T32)
Notice NOT-AI-22-007 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 9, 2021 Category: Research Source Type: funding
